Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype

European Journal of Neuroscience

Volumn 11, Issue 7, 1999, Pages 2351-2358

  Fedele, E ^a   Fontana, G ^a   Munari, C ^a   Cossu, M ^a   Raiteri, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Brain slices; Dopamine release; Human dopamine autoreceptors; Mesencephalic neuron cultures; Rat dopamine autoreceptors

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 7 DIPROPYLAMINO 2,3,5,6,7,8 HEXAHYDRONAPHTHO[2,3 B]FURAN; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; QUINPIROLE; SULPIRIDE;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; EMBRYO; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NEOCORTEX; NERVE CELL CULTURE; NERVE ENDING; PRIORITY JOURNAL;

EID: 0033046215     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00651.x     Document Type: Article

References (38)

1. L, ’hirondel, M., Chéramy, A., Godeheu, G., Artaud, F., Saiardi, A., Borrelli, E. & Glowinski, 1998 Lack of autoreceptor‐mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor‐deficient mice. Brain Res., 792, 253 262.
2. Agneter, E., Hoffmann, I.S., Singer, E.A., Cubeddu, L.X. 1994 Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons. J. Pharmacol. Exp. Ther., 269, 470 476.
3. Bergson, C., Mrzljak, L., Smiley, J.F., Pappy, M., Levenson, R., Goldman‐Rakic, P.S. 1995 Regional, cellular, and subcellular variations in the distribution of D 1 and D 5 dopamine receptors in primate brain. J. Neurosci., 15, 7821 7836.
4. Bianchi, C., Beani, L., Antonelli, T., Vedovato, M., Calo, G., Tomasini, C. 1992 A simple method for electrical field stimulation of cultured granule cells. J. Neurosci. Meth., 45, 175 182.
5. Bonanno, G. & Raiteri, M. 1987 Interaction between 5‐HT uptake inhibition and activation of 5‐HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes. Naunyn Schmiedebergs Arch. Pharmacol., 335, 219 225.
6. Bristow, L.J., Kramer, M.S., Kulagowski, J., Patel, S., Ragan, C.I., Seabrook, G.R. 1997 Schizophrenia and L‐745,870, a novel dopamine D4 receptor antagonist. Trends Pharmacol. Sci., 18, 186 188.
7. Clark, D. & White, F.J. 1987 Review: D 1 dopamine receptor – the search for a function: a critical evaluation of the D 1 /D 2 dopamine receptor classification and its functional implications. Synapse, 1, 347 388.
8. Damsma, G., Bottema, T., Westerink, B.H.C., Tepper, P.G., Dijkstra, D., Pugsley, T.A., MacKenzie, R.G., Heffner, T.G., Wikström, H. 1993 Pharmacological aspects of R‐(+) ‐7‐OH‐DPAT, a putative dopamine D 3 receptor ligand. Eur. J. Pharmacol., 249, R9 R10.
9. Fedele, E., Andrioli, G.C., Ruelle, A., Raiteri, M. 1993 Release‐regulating dopamine autoreceptors in human cerebral cortex. Br. J. Pharmacol., 110, 20 22.
10. Fitzgerald, S.C. 1989 Dissociated spinal cord‐dorsal root ganglion cultures on plastic tissue culture dishes and glass coverslips and wells. In: Shahar, A., de Vellis, J. Vernadakis, A. & Haber, eds. A Dissection and Tissue Culture Manual of the Nervous System. Alan R. Liss, New York, pp. 219 222.
11. Frankhuyzen, A.L. & Mulder, A.H. 1982 A cumulative dose–response technique for the characterization of presynaptic receptors modulating [ 3 H]noradrenaline release from rat brain slices. Eur. J. Pharmacol., 78, 91 97.
12. Furchgott, R.F. 1972 The Classification of Adrenoceptors ( Adrenergic Receptors). An evaluation from the standpoint of receptor theory. In Blaschko, H. & Muscholl, E, eds. Handbook of Experimental Pharmacology. Catecholamines, Vol. XXXIII. Springer, Berlin, pp. 283 335.
13. Gazi, L., Bobirnac, I., Danzeisen, M., Schupbach, E., Bruinvels, A.T., Geisse, S., Sommer, B., Hoyer, D., Tricklebank, M., Schoeffter, P. 1998 The agonist activities of the putative antipsychotic agents, L‐745,870 and U‐101958 in HEK293 cells expressing the human dopamine D‐4.4 receptor. Br. J. Pharmacol., 124, 889 896.
14. Gilbert, D.B., Millar, J., Cooper, S.J. 1995 The putative dopamine D 3 agonist, 7‐OH‐DPAT, reduces dopamine release in the nucleus accumbens and electrical self‐stimulation to the ventral tegmentum. Brain Res., 681, 1 7.
15. Gobert, A., Lejeune, F., Rivet, J.‐M., Cistarelli, L., Millan, M.J. 1996 Dopamine D 3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo. J. Neurochem., 66, 2209 2212.
16. Hoffmann, I.S., Talmaciu, R.K., Ferro, C.P., Cubeddu, L.X. 1988 Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals. J. Pharmacol. Exp. Ther., 245, 761 772.
17. Holz, G.G.I.V., Dunlap, K., Kream, R.M. 1988 Characterization of the electrically evoked release of substance P from dorsal root ganglion neurons: methods and dihydropyridine sensitivity. J. Neurosci., 8, 463 471.
18. Koeltzow, T.E., Xu, M., Cooper, D.C., Hu, X.‐T., Tonegawa, S., Wolf, M.E., White, F.J. 1998 Alterations in dopamine release but not dopamine autoreceptor function in dopamine D 3 receptor mutant mice. J. Neurosci., 18, 2231 2238.
19. Lahti, R.A., Roberts, R.C., Tamminga, C.A. 1995 D 2 ‐Family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport, 6, 2505 2512.
20. Lejeune, F. & Millan, M.J. 1995 Activation of dopamine D 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur. J. Pharmacol., 275, R7 R9.
21. Lidow, M.S., Goldman‐Rakic, P.S., Gallager, D.W., Rakic, P. 1991 Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [ 3 H]raclopride, [ 3 H]spiperone and [ 3 H]SCH23390. Neuroscience, 40, 657 671.
22. Lidow, M.S., Williams, G.V., Goldman‐Rakic, P.S. 1998 The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol. Sci., 19, 136 140.
23. Mercuri, N.B., Saiardi, A., Bonci, A., Picetti, R., Calabresi, P., Bernardi, G., Borrelli, E. 1997 Loss of autoreceptor function in dopaminergic neurons from dopaminergic D2 receptor deficient mice. Neuroscience, 79, 323 327.
24. Millan, M.J., Audinot, V., Rivet, J.‐M., Gobert, A., Vian, J., Prost, J.‐F., Spedding, M., Peglion, J.‐L. 1994 S 14297, a novel selective ligand at cloned human dopamine D 3 receptors, blocks 7‐OH‐DPAT‐induced hypothermia in rats. Eur. J. Pharmacol., 260, R3 R5.
25. Plantjè, J.F., Ducks, F.A., Verheijden, P.F.H.M., Stoof, J.C. 1985 Stimulation of D‐2 dopamine receptors in rat mesocortical areas inhibits the release of [ 3 H]dopamine. Eur. J. Pharmacol., 114, 401 402.
26. Pugsley, T.A., Davis, M.D., Akunne, H.C., MacKenzie, R.G., Shih, Y.H., Damsma, G. 1995 Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD‐128,907. J. Pharmacol. Exp. Ther., 275, 1355 1366.
27. Raiteri, M., Bonanno, G., Maura, G., Pende, M., Andrioli, G.C., Ruelle, A. 1992 Subclassification of release‐regulating α 2 ‐autoreceptors in human brain cortex. Br. J. Pharmacol., 107, 1146 1151.
28. Richards, M.H. 1985 Efflux of 3 H‐5‐hydroxytryptamine from rat hypothalamic slices by continuous electrical stimulation: frequency‐dependent responses to serotonergic antagonists and 5‐hydroxytryptamine. Naunyn Schmiedebergs Arch. Pharmacol., 329, 359 366.
29. Rivet, J.‐M., Audinot, V., Gobert, A., Peglion, J.‐L., Millan, M.J. 1994 Modulation of mesolimbic dopamine release by the selective dopamine D 3 receptor antagonist, (+) S 14297. Eur. J. Pharmacol., 265, 175 177.
30. Ronken, E., Van Muiswinkel, F.L., Mulder, A.H., Schoffelmeer, A.N.M. 1993 Opioid receptor‐mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. Eur. J. Pharmacol., 230, 349 355.
31. Routledge, C., Thorn, L., Ashmeade, T., Taylor, S. 1996 Elucidation of D 3 receptor function in vivo: do D 3 receptors mediate inhibition of dopamine neuronal activity? Biochem. Soc. Trans., 24, 199 201.
32. Seeman, P. & Van Tol, H.H.M. 1994 Dopamine receptor pharmacology. Trends Pharmacol. Sci., 15, 264 270.
33. Sokoloff, P. & Schwartz, J.‐C. 1995 Novel dopamine receptors half a decade later. Trends Pharmacol. Sci., 16, 270 275.
34. Starke, K., Göthert, M., Kilbinger, H. 1989 Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 864 989.
35. Tang, L., Todd, R.D., O’Malley, K.L. 1994 Dopamine D 2 and D 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther., 270, 475 479.
36. Tepper, J.M., Sun, B.‐C., Martin, L.P., Cresse, I. 1997 Functional roles of dopamine D 2 and D 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci., 17, 2519 2530.
37. Van Muiswinkel, F.L., Drukarch, B., Steinbusch, H.W.M., Stoof, J.C. 1993 Chronic dopamine D 2 receptor activation does not affect survival and differentiation of cultured dopaminergic neurons: morphological and neurochemical observations. J. Neurochem., 60, 83 92.
38. Wolf, M.E. & Roth, R.H. 1987 Dopamine neurons projecting to the medial prefrontal cortex possess release‐modulating autoreceptors. Neuropharmacology, 26, 1053 1059.